Selected research
Industry Research
Kidney Disease Management Software Industry Research Report 2026
Market perspective
The global Kidney Disease Management Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Kidney Disease Management Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Kidney Disease Management Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Kidney Disease Management Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Kidney Disease Management Software include Diaverum, MyRenalCare, Andersen Inc, iRen Medical, CSIRO, Baxter, Cricket Health, Bayer and Calcium LLC, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Kidney Disease Management Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Kidney Disease Management Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Kidney Disease Management Software Market by Company
Diaverum
MyRenalCare
Andersen Inc
iRen Medical
CSIRO
Baxter
Cricket Health
Bayer
Calcium LLC
Kidney Beam
Health Logic Interactive
Fresenius
SJH MiKidney
Healthify
Rimidi
Kidney Disease Management Software Segment by Type
Cloud-based
On-premises
Kidney Disease Management Software Segment by Application
Chronic Kidney Disease (CKD)
End Stage Renal Disease (ESRD)
Kidney Disease Management Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney Disease Management Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Kidney Disease Management Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney Disease Management Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Kidney Disease Management Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-based
- On-premises
Applications
- Chronic Kidney Disease (CKD)
- End Stage Renal Disease (ESRD)
Companies covered
- Diaverum
- MyRenalCare
- Andersen Inc
- iRen Medical
- CSIRO
- Baxter
- Cricket Health
- Bayer
- Calcium LLC
- Kidney Beam
- Health Logic Interactive
- Fresenius
- SJH MiKidney
- Healthify
- Rimidi
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Kidney Disease Management Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cloud-based
- 2.2.3 On-premises
- 2.3 Kidney Disease Management Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Chronic Kidney Disease (CKD)
- 2.3.3 End Stage Renal Disease (ESRD)
- 2.4 Assumptions and Limitations
3 Kidney Disease Management Software Breakdown Data by Type
- 3.1 Global Kidney Disease Management Software Historic Market Size by Type (2021-2026)
- 3.2 Global Kidney Disease Management Software Forecasted Market Size by Type (2027-2032)
4 Kidney Disease Management Software Breakdown Data by Application
- 4.1 Global Kidney Disease Management Software Historic Market Size by Application (2021-2026)
- 4.2 Global Kidney Disease Management Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Kidney Disease Management Software Market Perspective (2021-2032)
- 5.2 Global Kidney Disease Management Software Growth Trends by Region
- 5.2.1 Global Kidney Disease Management Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Kidney Disease Management Software Historic Market Size by Region (2021-2026)
- 5.2.3 Kidney Disease Management Software Forecasted Market Size by Region (2027-2032)
- 5.3 Kidney Disease Management Software Market Dynamics
- 5.3.1 Kidney Disease Management Software Industry Trends
- 5.3.2 Kidney Disease Management Software Market Drivers
- 5.3.3 Kidney Disease Management Software Market Challenges
- 5.3.4 Kidney Disease Management Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Kidney Disease Management Software Players by Revenue
- 6.1.1 Global Top Kidney Disease Management Software Players by Revenue (2021-2026)
- 6.1.2 Global Kidney Disease Management Software Revenue Market Share by Players (2021-2026)
- 6.2 Global Kidney Disease Management Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Kidney Disease Management Software Head Office and Area Served
- 6.4 Global Kidney Disease Management Software Players, Product Type & Application
- 6.5 Global Kidney Disease Management Software Manufacturers Established Date
- 6.6 Global Kidney Disease Management Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Kidney Disease Management Software Market Size (2021-2032)
- 7.2 North America Kidney Disease Management Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Kidney Disease Management Software Market Size by Country (2021-2026)
- 7.4 North America Kidney Disease Management Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Kidney Disease Management Software Market Size (2021-2032)
- 8.2 Europe Kidney Disease Management Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Kidney Disease Management Software Market Size by Country (2021-2026)
- 8.4 Europe Kidney Disease Management Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Kidney Disease Management Software Market Size (2021-2032)
- 9.2 Asia-Pacific Kidney Disease Management Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Kidney Disease Management Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Kidney Disease Management Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Kidney Disease Management Software Market Size (2021-2032)
- 10.2 South America Kidney Disease Management Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Kidney Disease Management Software Market Size by Country (2021-2026)
- 10.4 South America Kidney Disease Management Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Kidney Disease Management Software Market Size (2021-2032)
- 11.2 Middle East & Africa Kidney Disease Management Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Kidney Disease Management Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Kidney Disease Management Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Diaverum
- 12.1.1 Diaverum Company Information
- 12.1.2 Diaverum Business Overview
- 12.1.3 Diaverum Revenue in Kidney Disease Management Software Business (2021-2026)
- 12.1.4 Diaverum Kidney Disease Management Software Product Portfolio
- 12.1.5 Diaverum Recent Developments
- 12.2 MyRenalCare
- 12.2.1 MyRenalCare Company Information
- 12.2.2 MyRenalCare Business Overview
- 12.2.3 MyRenalCare Revenue in Kidney Disease Management Software Business (2021-2026)
- 12.2.4 MyRenalCare Kidney Disease Management Software Product Portfolio
- 12.2.5 MyRenalCare Recent Developments
- 12.3 Andersen Inc
- 12.3.1 Andersen Inc Company Information
- 12.3.2 Andersen Inc Business Overview
- 12.3.3 Andersen Inc Revenue in Kidney Disease Management Software Business (2021-2026)
- 12.3.4 Andersen Inc Kidney Disease Management Software Product Portfolio
- 12.3.5 Andersen Inc Recent Developments
- 12.4 iRen Medical
- 12.4.1 iRen Medical Company Information
- 12.4.2 iRen Medical Business Overview
- 12.4.3 iRen Medical Revenue in Kidney Disease Management Software Business (2021-2026)
- 12.4.4 iRen Medical Kidney Disease Management Software Product Portfolio
- 12.4.5 iRen Medical Recent Developments
- 12.5 CSIRO
- 12.5.1 CSIRO Company Information
- 12.5.2 CSIRO Business Overview
- 12.5.3 CSIRO Revenue in Kidney Disease Management Software Business (2021-2026)
- 12.5.4 CSIRO Kidney Disease Management Software Product Portfolio
- 12.5.5 CSIRO Recent Developments
- 12.6 Baxter
- 12.6.1 Baxter Company Information
- 12.6.2 Baxter Business Overview
- 12.6.3 Baxter Revenue in Kidney Disease Management Software Business (2021-2026)
- 12.6.4 Baxter Kidney Disease Management Software Product Portfolio
- 12.6.5 Baxter Recent Developments
- 12.7 Cricket Health
- 12.7.1 Cricket Health Company Information
- 12.7.2 Cricket Health Business Overview
- 12.7.3 Cricket Health Revenue in Kidney Disease Management Software Business (2021-2026)
- 12.7.4 Cricket Health Kidney Disease Management Software Product Portfolio
- 12.7.5 Cricket Health Recent Developments
- 12.8 Bayer
- 12.8.1 Bayer Company Information
- 12.8.2 Bayer Business Overview
- 12.8.3 Bayer Revenue in Kidney Disease Management Software Business (2021-2026)
- 12.8.4 Bayer Kidney Disease Management Software Product Portfolio
- 12.8.5 Bayer Recent Developments
- 12.9 Calcium LLC
- 12.9.1 Calcium LLC Company Information
- 12.9.2 Calcium LLC Business Overview
- 12.9.3 Calcium LLC Revenue in Kidney Disease Management Software Business (2021-2026)
- 12.9.4 Calcium LLC Kidney Disease Management Software Product Portfolio
- 12.9.5 Calcium LLC Recent Developments
- 12.10 Kidney Beam
- 12.10.1 Kidney Beam Company Information
- 12.10.2 Kidney Beam Business Overview
- 12.10.3 Kidney Beam Revenue in Kidney Disease Management Software Business (2021-2026)
- 12.10.4 Kidney Beam Kidney Disease Management Software Product Portfolio
- 12.10.5 Kidney Beam Recent Developments
- 12.11 Health Logic Interactive
- 12.11.1 Health Logic Interactive Company Information
- 12.11.2 Health Logic Interactive Business Overview
- 12.11.3 Health Logic Interactive Revenue in Kidney Disease Management Software Business (2021-2026)
- 12.11.4 Health Logic Interactive Kidney Disease Management Software Product Portfolio
- 12.11.5 Health Logic Interactive Recent Developments
- 12.12 Fresenius
- 12.12.1 Fresenius Company Information
- 12.12.2 Fresenius Business Overview
- 12.12.3 Fresenius Revenue in Kidney Disease Management Software Business (2021-2026)
- 12.12.4 Fresenius Kidney Disease Management Software Product Portfolio
- 12.12.5 Fresenius Recent Developments
- 12.13 SJH MiKidney
- 12.13.1 SJH MiKidney Company Information
- 12.13.2 SJH MiKidney Business Overview
- 12.13.3 SJH MiKidney Revenue in Kidney Disease Management Software Business (2021-2026)
- 12.13.4 SJH MiKidney Kidney Disease Management Software Product Portfolio
- 12.13.5 SJH MiKidney Recent Developments
- 12.14 Healthify
- 12.14.1 Healthify Company Information
- 12.14.2 Healthify Business Overview
- 12.14.3 Healthify Revenue in Kidney Disease Management Software Business (2021-2026)
- 12.14.4 Healthify Kidney Disease Management Software Product Portfolio
- 12.14.5 Healthify Recent Developments
- 12.15 Rimidi
- 12.15.1 Rimidi Company Information
- 12.15.2 Rimidi Business Overview
- 12.15.3 Rimidi Revenue in Kidney Disease Management Software Business (2021-2026)
- 12.15.4 Rimidi Kidney Disease Management Software Product Portfolio
- 12.15.5 Rimidi Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst